Mirae Asset Global Investments »

Acelyrin shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $127k 17k 7.46
2023-09-30 $205k 20k 10.17

More positions owned by Mirae Asset Global Investments

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices (AMD)
Intuitive Surgical Com New (ISRG)
Qualcomm (QCOM)

View all positions for Mirae Asset Global Investments

Top funds holding Acelyrin

Citadel Advisors
Vanguard Group
BlackRock
Opaleye Management
OrbiMed Advisors
venBio Partners
Artal Group
Jpmorgan Chase & Co
Samsara BioCapital
Ikarian Capital
Blue Owl Capital Holdings
Henderson Group
Decheng Capital
Logos Global Management
Kynam Capital Management

View all funds holding Acelyrin